Ramón
García Sanz
Profesor Titular de Universidad
Sir Charles Gairdner Hospital
Perth, AustraliaPublications in collaboration with researchers from Sir Charles Gairdner Hospital (2)
2020
-
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study
Blood, Vol. 136, Núm. 18, pp. 2038-2050
-
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: A substudy of the phase 3 ASPEN trial
Blood Advances, Vol. 4, Núm. 23, pp. 6009-6018